Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared ...
NORCROSS, Ga., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of galectin-3-targeted therapeutics for patients with MASH cirrhosis and portal ...
Retatrutide helped trial participants lose up to 28.7% of their body weight, but experts warn about excessive weight loss.
Although drug overdose deaths declined in the U.S. last year, the rate of substance use disorder is rising, and the problem ...
A Veterans Health Administration program in Michigan helped participants avoid more than 20,000 miles of travel and nearly $9,000 in travel-related costs.The Close to Me program allowed veterans to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results